surf break copy_edited.jpg

Ciitizen in Palo Alto Selects Healthcare Information Technology Industry Expert as Vice President of

Ciitizen, a healthcare technology company helping patients get full control of their medical records to access more personalized treatment options, including rapid participation in clinical trials, today announced the addition of Glenn Keet as the company’s VP of HIE strategy. Keet will bring both his experience with HIEs and his relationships with industry executives to accelerate Ciitizen’s goal of increasing data access to improve patient care and advance healthcare research.


Recent Posts

See All

Emerging Opportunities: Real-World Evidence

Key takeaways • Real-world evidence (RWE) has the potential to be useful across the entire healthcare ecosystem, including for clinical trials, care provision, determining treatment outcomes, and post

Invitae to Acquire Ciitizens

Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Ciitizen, a patient-centric consumer health tech company. Backed by a16z